House Subcommittee Recommends $137.7 Million Increase For NCI
In Brief: GM awards Shared By Six Scientists; Pollard Named President of Salk Institute
NCI Names Brawly Director of Office of Special Populations
Owens Becomes President, NCCR
FDA approves Irinotecan, Days After ODAC Meeting
ODAC Recommends FDA Approval For Grain Tumor Implant
Letter: Headline Criticized On Letter About Consortium
Trending Stories
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - Imaging’s ride to the bottom in clinical trials—and why it matters now
- In The Headlines: What happens when you apply a tumor board model to financial toxicity?